Literature DB >> 9127111

Effects of age, density, and geometry on the bending strength of human metatarsals.

A C Courtney1, B L Davis, T Manning, H E Kambic.   

Abstract

In this basic study, we investigated the relative roles of donor age, bone density, and bone geometry in determining structural strength of human metatarsals tested in a four-point bending configuration. Density measurements were made noninvasively using dual energy X-ray absorptiometry, and geometric measurements were made by digitally imaging cross-sections of specimens. Correlations between area bone mineral density and metatarsal strength were strong (r2 = 0.83, 0.81 for second and third metatarsals, respectively) and were not improved by including cross-sectional area or minimum moment of inertia in multiple regression analyses. Increased donor age was associated with decreased bending strength (r2 = 0.51 and 0.45, respectively), which was expected because increased age correlated significantly with decreased bone density (r2 = 0.69 and 0.80, respectively). These results indicate that the strength of human metatarsals generally decreases with age and that this decrease is likely attributable to decreased bone density. Moreover, the results indicate that noninvasive dual energy x-ray absorptiometry measurements of metatarsal density are useful for assessing metatarsal strength and that additional measurements of bone geometry are not required.

Entities:  

Mesh:

Year:  1997        PMID: 9127111     DOI: 10.1177/107110079701800406

Source DB:  PubMed          Journal:  Foot Ankle Int        ISSN: 1071-1007            Impact factor:   2.827


  8 in total

1.  Pedal bone density, strength, orientation, and plantar loads preceding incipient metatarsal fracture after charcot neuroarthropathy: 2 case reports.

Authors:  David J Gutekunst; David R Sinacore
Journal:  J Orthop Sports Phys Ther       Date:  2013-09-09       Impact factor: 4.751

2.  Second metatarsal stress fracture in sport: comparative risk factors between proximal and non-proximal locations.

Authors:  Bavornrit Chuckpaiwong; Chad Cook; Ricado Pietrobon; James A Nunley
Journal:  Br J Sports Med       Date:  2007-03-05       Impact factor: 13.800

3.  Predicting ex vivo failure loads in human metatarsals using bone strength indices derived from volumetric quantitative computed tomography.

Authors:  David J Gutekunst; Tarpit K Patel; Kirk E Smith; Paul K Commean; Matthew J Silva; David R Sinacore
Journal:  J Biomech       Date:  2012-12-06       Impact factor: 2.712

4.  Dual-energy X-ray absorptiometry of human metatarsals: precision, least significant change and association to ex vivo fracture force.

Authors:  Kathryn L Bohnert; David J Gutekunst; Charles F Hildebolt; David R Sinacore
Journal:  Foot (Edinb)       Date:  2013-05-31

5.  Impact of Charcot neuroarthropathy on metatarsal bone mineral density and geometric strength indices.

Authors:  David J Gutekunst; Kirk E Smith; Paul K Commean; Kathryn L Bohnert; Fred W Prior; David R Sinacore
Journal:  Bone       Date:  2012-10-29       Impact factor: 4.398

6.  Accelerated Cortical Osteolysis of Metatarsals in Charcot Neuroarthropathy: A Cross-Sectional Observational Study.

Authors:  David R Sinacore; Kirk E Smith; Kathryn L Bohnert; David J Gutekunst; Jeffrey E Johnson; Michael J Strube
Journal:  JBMR Plus       Date:  2019-11-05

7.  Reproducibility of a peripheral quantitative computed tomography scan protocol to measure the material properties of the second metatarsal.

Authors:  Elodie Chaplais; David Greene; Anita Hood; Scott Telfer; Verona du Toit; Davinder Singh-Grewal; Joshua Burns; Keith Rome; Daniel J Schiferl; Gordon J Hendry
Journal:  BMC Musculoskelet Disord       Date:  2014-07-19       Impact factor: 2.362

8.  Reliability of analysis of the bone mineral density of the second and fifth metatarsals using dual-energy x-ray absorptiometry (DXA).

Authors:  N Stewart Pritchard; James M Smoliga; Anh-Dung Nguyen; Micah C Branscomb; David R Sinacore; Jeffrey B Taylor; Kevin R Ford
Journal:  J Foot Ankle Res       Date:  2017-11-28       Impact factor: 2.303

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.